Suchergebnisse - "Park, Chan Kwon"

PubPharm (14)

1

Real-world outcome of crizotinib for anaplastic lymphoma kinase-positive lung cancer : Multicenter retrospective analysis in South Korea

enthalten in: Thoracic cancer | 2024

von Jeon, D. | Park, C. | Kim, S. | +15

2

Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer : Updated Analysis of the RESET Study

enthalten in: Cancer research and treatment | 2023

von Kim, T. | Jang, T. | Choi, C. | +14

3

Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer

enthalten in: Cancer research and treatment | 2023

von Lee, J. | Kim, E. | Park, C. | +19

4

First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South Korea

enthalten in: Anticancer research | 2022

von Kim, M. | Choi, C. | Lee, S. | +13

5

Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non-small-cell lung cancer harboring EGFR mutations : Results from a real-world study in South Korea

enthalten in: Cancer medicine | 2021

von Kim, T. | Jang, T. | Choi, C. | +14

6

Clinical impact of rebiopsy among patients with epidermal growth factor receptor-mutant lung adenocarcinoma in a real-world clinical setting

enthalten in: Thoracic cancer | 2021

von Nam, Y. | Kim, H. | Kim, Y. | +14

7

Comparison of PNA Clamping-assisted Fluorescence Melting Curve Analysis and PNA Clamping in Detecting EGFR Mutations in Matched Tumor Tissue, Cell Block, Pleural Effusion and Blood of Lung Cancer Patients With Malignant Pleural Effusion

enthalten in: In vivo (Athens, Greece) | 2019

von Jeon, S. | Kim, H. | Kim, B. | +12

8

PD-L1 expression in ROS1-rearranged non-small cell lung cancer : A study using simultaneous genotypic screening of EGFR, ALK, and ROS1

enthalten in: Thoracic cancer | 2019

von Lee, J. | Park, C. | Yoon, H. | +5

9

Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2015

von Yeo, C. | Park, K. | Park, C. | +7

10

Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations

enthalten in: PloS one | 2015

von Lim, J. | Yeo, C. | Rhee, C. | +9